Florfenicol concentrations in ovine tear fluid following intramuscular and subcutaneous administration and comparison with the minimum inhibitory concentrations against mycoplasmal strains potentially involved in infectious keratoconjunctivitis

American Journal of Veterinary Research

Volumn 74, Issue 2, 2013, Pages 268-274

  Regnier, Alain ^a   Laroute, Valérie ^b   Gautier Bouchardon, Anne ^c   Gayrard, Véronique ^a   Picard Hagen, Nicole ^a   Toutain, Pierre Louis ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b UMR792 INGÉNIERIE DES SYSTÈMES BIOLOGIQUES ET DES PROCÉDÉS   (France)

^c FRENCH AGENCY FOR FOOD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FLORFENICOL; PREDNISOLONE;

AGAR DILUTION; ANIMAL EXPERIMENT; ANTIBIOTIC SENSITIVITY; ARTICLE; COMPARATIVE STUDY; CROSSOVER PROCEDURE; DRUG BLOOD LEVEL; EWE; FEMALE; GOAT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; KERATOCONJUNCTIVITIS; LACRIMAL FLUID; MINIMUM INHIBITORY CONCENTRATION; MYCOPLASMA; MYCOPLASMA AGALACTIAE; MYCOPLASMA CONJUNCTIVAE; MYCOPLASMA MYCOIDES; NONHUMAN;

ANIMALS; ANTI-BACTERIAL AGENTS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CROSS-OVER STUDIES; FEMALE; INJECTIONS, INTRAMUSCULAR; INJECTIONS, SUBCUTANEOUS; KERATOCONJUNCTIVITIS, INFECTIOUS; MICROBIAL SENSITIVITY TESTS; MYCOPLASMA; MYCOPLASMA INFECTIONS; SHEEP; SHEEP DISEASES; SPECIES SPECIFICITY; TEARS; THIAMPHENICOL;

EID: 84873372185     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.74.2.268     Document Type: Article

References (49)

1. Hosie BD. Keratoconjunctivitis in a hill sheep flock. Vet Rec 1988;122:40-43.
2. Egwu GO, Faull WB, Bradbury JM, et al. Ovine infectious keratoconjunctivitis: a microbiological study of clinically unaffected and affected sheep's eyes with special reference to Mycoplasma conjunctivae. Vet Rec 1989;125:253-256.
3. Jones GE. Infectious keratoconjunctivitis. In: Martin WB, Aitken ID, eds. Diseases of sheep. 2nd ed. London: Blackwell Scientific Publications, 1991;280-283.
4. Baas EJ, Trotter SL, Franklin RM, et al. Epidemic caprine keratoconjunctivitis: recovery of Mycoplasma conjunctivae and its possible role in pathogenesis. Infect Immun 1977;18:806-815.
5. Giacometti M, Janosvky M, Belloy L, et al. Infectious keratoconjunctivitis of ibex, chamois and other caprinae. Rev Sci Tech 2002;21:335-345.
6. Dziezyc J, Millichamp NJ. Infectious ocular diseases. In: Smith BP, ed. Large animal internal medicine. 3rd ed. St Louis: Mosby, 2002;1164-1182.
7. Radostits OM, Gay CC, Hindchcliff KW, et al. Diseases of the skin, conjunctiva, and external ears. In: Radostits OM, Gay CC, Hinchcliff KW, et al. Veterinary medicine. A textbook of the diseases of cattle, horses, sheep, pigs and goats. 10th ed. Edinburgh: Saunders Elsevier; 2007;651-671.
8. Whittaker CJG, Gelatt KN, Wilkie DA. Food animal ophthalmology. In: Gelatt KN, ed. Veterinary ophthalmology. 3rd ed. Philadelphia: Lippincott Williams & Wilkins, 1991;1117-1176.
9. Naglic T, Hajsig D, Frey J, et al. Epidemiologic and microbiological study of an outbreak of infectious keratoconjunctivitis in sheep. Vet Rec 2000;147:72-75.
10. Jones GE, Foggie A, Sutherland A, et al. Mycoplasmas and ovine keratoconjunctivitis. Vet Rec 1976;99:137-141.
11. Ter Laak EA, Schreuder BEC, Kimman TG, et al. Ovine keratoconjunctivitis experimentally induced by inoculation of Mycoplasma conjunctivae. Vet Q 1988;10:217-224.
12. Van Halderen A, Van Rensburg WJJ, Geyer A, et al. The identification of Mycoplasma conjunctivae as an aetiological agent of infectious keratoconjunctivitis of sheep in South Africa. Onderstepoort J Vet Res 1994;61:231-237.
13. Nicolet J, Freundt EA. Isolation of Mycoplasma conjunctivae from chamois and sheep affected with kerato-conjunctivitis. Zentralbl Veterinarmed B 1975;22:302-307.
14. Dagnall GJR. The role of Branhamella ovis, Mycoplasma conjunctivae and Chlamydia psittaci in conjunctivitis of sheep. Br Vet J 1994;150:65-71.
15. Motha MXJ, Frey J, Hansen MF, et al. Detection of Mycoplasma conjunctivae in sheep affected with conjunctivitis and infectious keratoconjunctivitis. N Z Vet J 2003;51:186-190.
16. Rodriguez JL, Poveda JB, Rodriguez F, et al. Ovine infectious keratoconjunctivitis caused by Mycoplasma agalactiae. Small Rumin Res 1996;22:93-96.
17. Nouws JFM, König CDW. Penetration of some antibiotics into the lacrimal fluid of sheep. Vet Q 1983;5:114-121.
18. König CDW. "Pink eye" or "zere oogies" or keratoconjunctivitis infectiosa ovis (KIO). Clinical efficacy of a number of antimicrobial therapies. Vet Q 1983;5:122-127.
19. Neu HC, Fu KP. In vitro activity of chloramphenicol and thiamphenicol analogs. Antimicrob Agents Chemother 1980;18:311-316.
20. Graham R, Palmer D, Pratt BC, et al. In vitro activity of florfenicol. Eur J Clin Microbiol Infect Dis 1988;7:691-694.
21. Ali BH, Al-Qarawi AA, Hashaad M. Comparative plasma pharmacokinetics and tolerance of florfenicol following intramuscular and intravenous administration to camels, sheep and goats. Vet Res Commun 2003;27:475-483.
22. Jianzhong S, Xiubo L, Haiyang J, et al. Bioavailability and pharmacokinetics of florfenicol in healthy sheep. J Vet Pharmacol Ther 2004;27:163-168.
23. Lane VM, Wetzlich S, Clifford A, et al. Intravenous and subcutaneous pharmacokinetics of florfenicol in sheep. J Vet Pharmacol Ther 2004;27:191-196.
24. Bretzlaff KN, Neff-Davis CA, Ott RS, et al. Florfenicol in nonlactating dairy cows: pharmacokinetics, binding to plasma proteins, and effect on phagocytosis by blood neutrophils. J Vet Pharmacol Ther 1987;10:233-240.
25. Lobell RD, Varma KJ, Johnson JC, et al. Pharmacokinetics of florfenicol following intravenous and intramuscular doses to cattle. J Vet Pharmacol Ther 1994;17:253-258.
26. Monaco F, Mutani R, Mastropaolo C, et al. Tears as the best practical indicator of the unbound fraction of an anticonvulsant. Epilepsia 1979;20:705-710.
27. Van Haeringen NJ. Secretion of drugs in tears. Curr Eye Res 1985;4:485-488.
28. Dueger EL, Angelos JA, Cosgrove S, et al. Efficacy of florfenicol in the treatment of experimentally induced infectious bovine keratoconjunctivitis. Am J Vet Res 1999;60:960-964.
29. Angelos JA, Dueger EL, George LW, et al. Efficacy of florfenicol for treatment of naturally occurring IBK. J Am Vet Med Assoc 2000;216:62-64.
30. Gokce HI, Mehmet C, Genc O, et al. A comparison of the efficacy of florfenicol and oxytetracycline in the treatment of naturally occurring infectious bovine keratoconjunctivitis. Irish Vet J 2002;55:573-576.
31. Tang-Liu D, Schwob DL, Usansky JI, et al. Comparative tear concentrations over time of ofloxacin and tobramycin in human eyes. Clin Pharmacol Ther 1994;55:284-292.
32. Akkan AG, Mutlu I, Özyazgan S, et al. Comparative tear concentrations of topically applied ciprofloxacin, ofloxacin, and norfloxacin in human eyes. Int J Clin Pharmacol Ther 1997;35:214-217.
33. Small D, Hevy J, Tang-Liu D. Comparison of tear sampling techniques for pharmacokinetic analysis: ofloxacin concentrations in rabbit tears after sampling with Schirmer tear strips, capillary tubes, or surgical sponges. J Ocul Pharmacol 2000;16:439-446.
34. Friis NF. Selective isolation of slowly growing acidifying mycoplasmas from swine and cattle. Acta Vet Scand 1979;20:607-609.
35. Bébéar C, Robertson JA. Determination of minimal inhibitory concentration. In: Tully JG, Razin S, eds. Molecular and diagnostic procedures in mycoplasmology. Volume II: diagnostic procedures. New York: Academic Press, 1996;189-197.
36. Hannan PCT. Guidelines and recommendations for antimicrobial minimum inhibitory concentration (MIC) testing against veterinary Mycoplasma species. Vet Res 2000;31:373-395.
37. George LW, Reina-Guerra M, Baggot JD, et al. Distribution of kanamycin in ocular tissues of calves. J Vet Pharmacol Ther 1986;9:183-191.
38. Woo FL, Johnson AP, Insler MS, et al. Gentamicin, tobramycin, amikacin, and netilmicin levels in tears following intravenous administration. Arch Ophthalmol 1985;103:216-218.
39. George LW, Smith JA, Kaswan R. Distribution of oxytetracycline into ocular tissues and tears of calves. J Vet Pharmacol Ther 1985;8:47-54.
40. De Craene BA, Deprez P, D'Haese E, et al. Pharmacokinetics of florfenicol in cerebrospinal fluid and plasma of calves. Antimicrob Agents Chemother 1997;41:1991-1995.
41. Pilo P, Fleury B, Marenda M, et al. Prevalence and distribution of the insertion element ISMagI in Mycoplasma agalactiae. Vet Microbiol 2003;92:37-48.
42. Marenda MS, Sagné E, Poumarat F, et al. Suppression subtractive hybridization as a basis to asses Mycoplasma agalactiae and Mycoplasma bovis genomic diversity and species-specific sequences. Microbiology 2005;151:475-489.
43. Rosenbuch RF, Kinyon JM, Apley M, et al. In vitro antimicrobial inhibition profiles of Mycoplasma bovis isolates recovered from various regions of the United States from 2002 to 2003. J Vet Diagn Invest 2005;17:436-441.
44. Ayling RD, Baker SE, Nicholas RAJ, et al. Comparison of in vitro activity of danofloxacin, florfenicol, oxytetracycline, spectinomycin and tilmicosin against Mycoplasma mycoides subspecies mycoides small colony type. Vet Rec 2000;146:243-246.
45. Kidanemariam A, Gouws J, van Vuuren M, et al. In vitro antimicrobial susceptibility of Mycoplasma mycoides mycoides large colony and Arcanobacterium pyogenes isolated from clinical cases of ulcerative balanitis and vulvitis in Dorper sheep in South Africa. J S Afr Vet Assoc 2005;76:204-208.
46. Al-Momani W, Nicholas RAJ, Janakat S, et al. The in vitro effect of six antimicrobials against Mycoplasma putrefaciens, Mycoplasma mycoides subsp. mycoides LC and Mycoplasma capricolum subsp. capricolum isolated from sheep and goats in Jordan. Trop Anim Health Prod 2006;38:1-7.
47. Antunes NT, Tavío MM, Assunção P, et al. In vitro susceptibilities of field isolates of Mycoplasma agalactiae. Vet J 2008;177:436-438.
48. National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial disk and dilution susceptibility tests for bacteria isolated from animals. 2nd ed. Approved standards. NCCLS document M31-A2. Wayne, Pa: National Committee for Clinical Laboratory Standards, 2002.
49. Toutain PL, Del Castillo JRE, Bousquet-Mélou A. The pharmacokinetic- pharmacodynamic approach to a rational dosage regimen for antibiotics. Res Vet Sci 2002;73:105-114.